to cancel last minute raises eyebrows. my view on it is that we...

to cancel last minute raises eyebrows. my view on it is that we have a major announcement at the CC probably with the cpulse2 news ?

either way , higher enrollments and details of the interim analysis will get us forward.

volume has been relentless for the past 6 days , more so than anytime in the history of the company ( nasdaq )
my view is institutions buying cheaply and who can blame them ! amazing opportunity to buy. the interim analysis approval is huge news for the company and for us investors , dont let the lack of price momentum negate the fact that this event is a turning point for the success of the company.

a cfo wouldnt leave medtronic to join a sub 100m company unless something is brewing. a vp of clinical trials wouldnt leave medtronic to head the trials for a sub 100m company. look around the board , the chairman and warren watson. this has a buyout all over it.
though i doubt they would settle for anything less than $1.5b. if we move forward with the same success 3-5b would be peanuts for medtronic or another giant.
things can change fast and a jump from 5 to 50s can happen faster than we think.
this investment isnt a golden ticket for us only , it is to management and the board and everyone involved as well.

18 months from now